2020-10-20

1: Lord B, Ameriks MK, Wang Q, Fourgeaud L, Vliegen M, Verluyten W, Haspeslagh P, 
Carruthers NI, Lovenberg TW, Bonaventure P, Letavic MA, Bhattacharya A. A novel 
radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334. Eur J 
Pharmacol. 2015 Oct 15;765:551-9. doi: 10.1016/j.ejphar.2015.09.026. PubMed PMID: 
26386289.

2: Antonioli L, Giron MC, Colucci R, Pellegrini C, Sacco D, Caputi V, Orso G, 
Tuccori M, Scarpignato C, Blandizzi C, Fornai M. Involvement of the P2X7 
purinergic receptor in colonic motor dysfunction associated with bowel 
inflammation in rats. PLoS One. 2014 Dec 30;9(12):e116253. doi: 
10.1371/journal.pone.0116253. PubMed PMID: 25549098; PubMed Central PMCID: 
PMC4280204.

3: Catanzaro JM, Hueston CM, Deak MM, Deak T. The impact of the P2X7 receptor 
antagonist A-804598 on neuroimmune and behavioral consequences of stress. Behav 
Pharmacol. 2014 Sep;25(5-6):582-98. doi: 10.1097/FBP.0000000000000072. PubMed 
PMID: 25083574.

4: Able SL, Fish RL, Bye H, Booth L, Logan YR, Nathaniel C, Hayter P, Katugampola 
SD. Receptor localization, native tissue binding and ex vivo occupancy for 
centrally penetrant P2X7 antagonists in the rat. Br J Pharmacol. 2011 
Jan;162(2):405-14. doi: 10.1111/j.1476-5381.2010.01025.x. PubMed PMID: 20840537; 
PubMed Central PMCID: PMC3031061.

5: Donnelly-Roberts DL, Namovic MT, Surber B, Vaidyanathan SX, Perez-Medrano A, 
Wang Y, Carroll WA, Jarvis MF. [3H]A-804598 
([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, 
and selective antagonist radioligand for P2X7 receptors. Neuropharmacology. 2009 
Jan;56(1):223-9. doi: 10.1016/j.neuropharm.2008.06.012. PubMed PMID: 18602931.